These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 27620969)

  • 1. Pyrazole-based potent inhibitors of GGT1: Synthesis, biological evaluation, and molecular docking studies.
    Mansha M; Kumari UU; Cournia Z; Ullah N
    Eur J Med Chem; 2016 Nov; 124():666-676. PubMed ID: 27620969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and molecular modeling of pyrazole-quinoline-pyridine hybrids as a new class of antimicrobial and anticancer agents.
    Sangani CB; Makawana JA; Zhang X; Teraiya SB; Lin L; Zhu HL
    Eur J Med Chem; 2014 Apr; 76():549-57. PubMed ID: 24607998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of new phenothiazine derivatives bearing a pyrazole unit as protein farnesyltransferase inhibitors.
    Baciu-Atudosie L; Ghinet A; Farce A; Dubois J; Belei D; Bîcu E
    Bioorg Med Chem Lett; 2012 Nov; 22(22):6896-902. PubMed ID: 23036952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting protein prenylation for cancer therapy.
    Berndt N; Hamilton AD; Sebti SM
    Nat Rev Cancer; 2011 Oct; 11(11):775-91. PubMed ID: 22020205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel protein geranylgeranyltransferase-I inhibitor with high potency, selectivity, and cellular activity.
    Peterson YK; Kelly P; Weinbaum CA; Casey PJ
    J Biol Chem; 2006 May; 281(18):12445-50. PubMed ID: 16517596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and characterization of piperazinedione-based dual protein inhibitors for both farnesyltransferase and geranylgeranyltransferase-I.
    Qiao Y; Gao J; Qiu Y; Wu L; Guo F; Lo KK; Li D
    Eur J Med Chem; 2011 Jun; 46(6):2264-73. PubMed ID: 21440964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and biological evaluation of novel 5-phenyl-1H-pyrazole derivatives as potential BRAF(V600E) inhibitors.
    Wang SF; Zhu YL; Zhu PT; Makawana JA; Zhang YL; Zhao MY; Lv PC; Zhu HL
    Bioorg Med Chem; 2014 Nov; 22(21):6201-8. PubMed ID: 25267006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of 1H-pyridin-2-one derivatives as potent and selective farnesyltransferase inhibitors.
    Wang L; Lin NH; Li Q; Henry RF; Zhang H; Cohen J; Gu WZ; Marsh KC; Bauch JL; Rosenberg SH; Sham HL
    Bioorg Med Chem Lett; 2004 Sep; 14(18):4603-6. PubMed ID: 15324873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel pyrazole-5-carboxamide and pyrazole-pyrimidine derivatives: synthesis and anticancer activity.
    Shi JB; Tang WJ; Qi XB; Li R; Liu XH
    Eur J Med Chem; 2015 Jan; 90():889-96. PubMed ID: 25554922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models.
    Lobell RB; Omer CA; Abrams MT; Bhimnathwala HG; Brucker MJ; Buser CA; Davide JP; deSolms SJ; Dinsmore CJ; Ellis-Hutchings MS; Kral AM; Liu D; Lumma WC; Machotka SV; Rands E; Williams TM; Graham SL; Hartman GD; Oliff AI; Heimbrook DC; Kohl NE
    Cancer Res; 2001 Dec; 61(24):8758-68. PubMed ID: 11751396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and Biological Evaluation of Novel Aryl-2H-pyrazole Derivatives as Potent Non-purine Xanthine Oxidase Inhibitors.
    Sun ZG; Zhou XJ; Zhu ML; Ding WZ; Li Z; Zhu HL
    Chem Pharm Bull (Tokyo); 2015; 63(8):603-7. PubMed ID: 26040271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, biological evaluation and 3D-QSAR study of novel 4,5-dihydro-1H-pyrazole thiazole derivatives as BRAF(V⁶⁰⁰E) inhibitors.
    Zhao MY; Yin Y; Yu XW; Sangani CB; Wang SF; Lu AM; Yang LF; Lv PC; Jiang MG; Zhu HL
    Bioorg Med Chem; 2015 Jan; 23(1):46-54. PubMed ID: 25496804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyrazole-based cathepsin S inhibitors with arylalkynes as P1 binding elements.
    Ameriks MK; Axe FU; Bembenek SD; Edwards JP; Gu Y; Karlsson L; Randal M; Sun S; Thurmond RL; Zhu J
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6131-4. PubMed ID: 19773165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, Synthesis, and Biological Evaluation of Pyrazole Derivatives.
    Hu C; Gao Y; Du W
    Chem Biol Drug Des; 2016 May; 87(5):673-9. PubMed ID: 26648479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, biological evaluation and molecular docking studies of pyrazole derivatives coupling with a thiourea moiety as novel CDKs inhibitors.
    Sun J; Lv XH; Qiu HY; Wang YT; Du QR; Li DD; Yang YH; Zhu HL
    Eur J Med Chem; 2013 Oct; 68():1-9. PubMed ID: 23933045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the prenylation of K-Ras, but not H- or N-Ras, is highly resistant to CAAX peptidomimetics and requires both a farnesyltransferase and a geranylgeranyltransferase I inhibitor in human tumor cell lines.
    Lerner EC; Zhang TT; Knowles DB; Qian Y; Hamilton AD; Sebti SM
    Oncogene; 1997 Sep; 15(11):1283-8. PubMed ID: 9315095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, in vitro Antiproliferative and Antiinflammatory Activities, and Kinase Inhibitory effects of New 1,3,4-triarylpyrazole Derivatives.
    El-Gamal MI; Abdel-Maksoud MS; Gamal El-Din MM; Shin JS; Lee KT; Yoo KH; Oh CH
    Anticancer Agents Med Chem; 2017; 17(1):75-84. PubMed ID: 27334850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, anti-inflammatory, analgesic, COX1/2-inhibitory activity, and molecular docking studies of hybrid pyrazole analogues.
    Alam MJ; Alam O; Khan SA; Naim MJ; Islamuddin M; Deora GS
    Drug Des Devel Ther; 2016; 10():3529-3543. PubMed ID: 27826185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and biological evaluation of N-((1-benzyl-1H-1,2,3-triazol-4-yl)methyl)-1,3-diphenyl-1H-pyrazole-4-carboxamides as CDK1/Cdc2 inhibitors.
    Ganga Reddy V; Srinivasa Reddy T; Lakshma Nayak V; Prasad B; Reddy AP; Ravikumar A; Taj S; Kamal A
    Eur J Med Chem; 2016 Oct; 122():164-177. PubMed ID: 27344493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and structure-activity relationships of pyrazolo-[3,4-b]pyridine derivatives as adenosine 5'-monophosphate-activated protein kinase activators.
    Zheng B; Peng Y; Wu W; Ma J; Zhang Y; Guo Y; Sun S; Chen Z; Li Q; Hu G
    Arch Pharm (Weinheim); 2019 Aug; 352(8):e1900066. PubMed ID: 31373047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.